Trischitta, V.* et al. Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta Diabetol. 61, 1015-1015 (2024)
Trischitta, V.* et al. GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta Diabetol. 61, 1007-1013 (2024)
Casas, R.* et al. Intra-lymphatic administration of GAD-alum in type 1 diabetes: Long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial). Acta Diabetol. 59, 687-696 (2022)
Schmitz, T.* et al. Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction. Acta Diabetol. 59, 1019-1029 (2022)
Kabisch, S.* et al. Dose-dependent effects of insoluble fibre on glucose metabolism: A stratified post hoc analysis of the Optimal Fibre Trial (OptiFiT). Acta Diabetol., DOI: 10.1007/s00592-021-01772-0 (2021)
Ferrari, U.* et al. Longitudinal association of type 2 diabetes and insulin therapy with muscle parameters in the KORA-Age study. Acta Diabetol. 57, 1057-1063 (2020)
Greiner, G. et al. Toward targeted prevention: Risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany. Acta Diabetol. 57, 1481-1491 (2020)
Klöting, N. ; Kern, M.* ; Moruzzi, M.* ; Stumvoll, M. & Blüher, M. Tamoxifen treatment causes early hepatic insulin resistance. Acta Diabetol. 57, 495-498 (2020)
Mühlenbruch, K.* et al. Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: A cost-effectiveness analysis. Acta Diabetol. 57, 447-454 (2020)
Hippich, M. et al. Searching peripheral blood mononuclear cells of children with viral respiratory tract infections preceding islet autoimmunity for viruses by high-throughput sequencing. Acta Diabetol. 55, 881-884 (2018)
Liberati, D.* et al. A novel LIPS assay for insulin autoantibodies. Acta Diabetol. 55, 263–270 (2018)
Mendler, M.* et al. Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes. Acta Diabetol. 55, 585-592 (2018)
Köhler, M. et al. Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: Results from the TEDDY study. Acta Diabetol. 54, 1009–1017 (2017)
Wagner, R. et al. Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 54, 713-714 (2017)
Köhler, M. ; Ziegler, A.-G. & Beyerlein, A. Development of a simple tool to predict the risk of postpartum diabetes in women with gestational diabetes mellitus. Acta Diabetol. 53, 433-437 (2016)
Wagner, R. et al. A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 53, 1037-1044 (2016)
Chmiel, R. et al. Early infant feeding and risk of developing islet autoimmunity and type 1 diabetes. Acta Diabetol. 52, 621-624 (2015)
Then, C. et al. Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study. Acta Diabetol. 52, 103-112 (2015)
Bonifacio, E.* ; Krumsiek, J. ; Winkler, C. ; Theis, F.J. & Ziegler, A.-G. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol. 51, 403-411 (2014)
Krause, S. et al. Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes. Acta Diabetol. 51, 517-518 (2014)
Wagner, R.* et al. Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol. 51, 71-78 (2014)
Heni, M. et al. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans. Acta Diabetol. 51, 679-681 (2013)